Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects (Q44334951)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects (English)

1 reference

Europe PubMed Central

2 December 2017

0 references

0 references

positron emission tomography

1 reference

based on heuristic

inferred from title

Elise M. Weerts

1

1 reference

Europe PubMed Central

2 December 2017

7

object named as

Mary E McCaul

1 reference

Europe PubMed Central

2 December 2017

Robert F Dannals

4

object named as

Robert F Dannals

1 reference

Europe PubMed Central

2 December 2017

author name string

Yu Kyeong Kim

2

1 reference

Europe PubMed Central

2 December 2017

Gary S Wand

3

1 reference

Europe PubMed Central

2 December 2017

Jae Sung Lee

5

1 reference

Europe PubMed Central

2 December 2017

J James Frost

6

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

9 May 2007

1 reference

Europe PubMed Central

2 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

2 December 2017

33

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

653-665

1 reference

Europe PubMed Central

2 December 2017

describes a project that uses

positron emission tomography

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301440

0 references

Alteration of ethanol self-administration by naltrexone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Naltrexone blockade of nicotine effects in cigarette smokers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Distribution of opioid peptide gene expression in the limbic system of Fawn-Hooded (alcohol-preferring) and Wistar-Kyoto (alcohol-non-preferring) rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

The effects of benzodiazepines on human opioid receptor binding and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Selected opioids modify intake of sweetened ethanol solution among female rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Enhanced activity of the brain beta-endorphin system by free-choice ethanol drinking in C57BL/6 but not DBA/2 mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

The effect of chronic ethanol consumption and withdrawal on mu-opioid and dopamine D(1) and D(2) receptor density in Fawn-Hooded rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Modulation of volitional ethanol intake in the rat by central delta-opioid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Importance of delta opioid receptors in maintaining high alcohol drinking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Endogenous opioids and addiction to alcohol and other drugs of abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Differences in the brain and pituitary beta-endorphin system between the alcohol-preferring AA and alcohol-avoiding ANA rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Endogenous opioid systems and alcohol addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Naltrexone alteration of acute smoking response in nicotine-dependent subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

In vivo binding of N1'-([11C]methyl)naltrindole to delta-opioid receptors in mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Intracerebroventricular morphine enhances alcohol consumption by rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Distribution volume ratios without blood sampling from graphical analysis of PET data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Pharmacotherapy of alcohol dependence: a review of the clinical data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Quantitative autoradiography of mu-opioid receptors in the CNS of alcohol-naive alcohol-preferring P and -nonpreferring NP rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Nicotinic and opioid receptor interactions in nicotine addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Morphine increases intake of beer among rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Opioids and alcoholism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Endogenous opioids and smoking: a review of progress and problems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Neuroendocrine reactivity to nicotine in smokers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

What place does naltrexone have in the treatment of alcoholism?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Oral ethanol self-administration in the rat: effect of naloxone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Current and emerging pharmacotherapies for treating tobacco dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Brain opioid receptor binding of [3H]CTOP and [3H]naltrindole in alcohol-preferring AA and alcohol-avoiding ANA rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Mu-opioid receptor and CREB activation are required for nicotine reward

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Adrenocortical responses and family history of alcoholism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Gender and age influences on human brain mu-opioid receptor binding measured by PET.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

21 January 2018

Current pharmacotherapies of alcoholism: a U.S. perspective.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional brain [Met]-enkephalin in alcohol-preferring and non-alcohol-preferring inbred strains of mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Imaging opiate receptors in the human brain by positron tomography.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Alcohol dependence syndrome: measurement and validation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Naltrexone and alcohol dependence. Role of subject compliance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301440

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301440

1 reference

Europe PubMed Central

2 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44334951&oldid=2109498562"